Format

Send to

Choose Destination
Int J Hyperthermia. 2017 May;33(3):295-299. doi: 10.1080/02656736.2016.1244707. Epub 2016 Nov 15.

Benign thyroid nodules treatment using percutaneous laser ablation (PLA) and radiofrequency ablation (RFA).

Author information

1
a Division of Interventional Oncology , European Institute of Oncology , Milan , Italy.
2
b Radiology Service, IRCCS Policlinico San Donato , Milan , Italy.
3
c Interventional Oncology Service, Azienda Socio-Sanitario Territoriale (ASST) della Valle Olona , Varese , Italy.
4
d Postgraduate School in Radiodiagnostic Imaging, University of Milan , Milan , Italy.
5
e Department of Biomedical Sciences for Health , University of Milan , Milan , Italy.
6
f Endocrinology Unit, IRCCS Policlinico San Donato , Milano , Italy.
7
g Department of Clinical Sciences and Community Health, University of Milan, IRCCS Policlinico San Donato , Milan , Italy.
8
h Department of Nuclear Medicine, Azienda Socio-Sanitario Territoriale (ASST) della Valle Olona , Varese , Italy.
9
i Unit of Interventional Radiology, Istituto Clinico Humanitas , Milano , Italy.
10
j Humanitas University, Istituto Clinico Humanitas , Milano , Italy.

Abstract

PURPOSE:

To evaluate the reduction over time of benign thyroid nodules treated using percutaneous laser ablation (PLA) and radiofrequency ablation (RFA) by the same equipe.

MATERIALS AND METHODS:

Ninety patients (age 55.6 ± 14.1 years) underwent ablation for benign thyroid nodule causing compression/aesthetic dissatisfaction from 2011. Fifty-nine (age 55.8 ± 14.1 years) underwent RFA and 31 (age 55.2 ± 14.2 years) PLA, ultrasound guided. Technical success, complications, duration of ablation and treatment, energy deployed, volumetric percentage reduction at 1, 6 and 12 months were derived. A regression model for longitudinal measurements was used with random intercept and random slope. Values are expressed as mean ± standard deviation or N (%).

RESULTS:

Technical success was always obtained. No major complications occurred. Mean ablation time was 30.1 ± 13.8 vs. 13.9 ± 5.9 min (p < .0001) and mean energy deployment was 5422.3 ± 2484.5 J vs. 34 662.7 ± 15 812.3 J in PLA vs. RFA group. Mean volume reduced from 20.3 ± 16.4 ml to 13.17 ± 10.74 ml (42% ± 17% reduction) at 1st month, 8.7 ± 7.4 ml (60% ± 15% reduction) at 6th month and 7.1 ± 7.7 ml (70%% ± 16% reduction) at 12th month, in PLA group, and from 32.7 ± 19.5 ml to 17.2 ± 12.9 ml (51%±15% reduction) at 1st month, 12.8 ± 9.6 ml (64 ± 14% reduction) at 6th month and 9.9 ± 9.2 ml (74% ± 14% reduction) at 12th month in RFA group. No difference in time course of the relative volume reduction between the two techniques was found.

CONCLUSIONS:

RFA and PLA are similarly feasible, safe and effective in treating benign thyroid nodules when performed by the same equipe. RFA is faster than PLA but require significantly higher energy.

KEYWORDS:

Thyroid nodule; laser; percutaneous ablation; radiofrequency; ultrasound

PMID:
27701923
DOI:
10.1080/02656736.2016.1244707
Free full text

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for Archivio Istituzionale della Ricerca Unimi
Loading ...
Support Center